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http://www.biomedcentral.com/1472-6750/12/31RESEARCH ARTICLE Open AccessA stepwise approach for the reproducible
optimization of PAMO expression in Escherichia
coli for whole-cell biocatalysis
Edwin van Bloois1,2, Hanna M Dudek1, Wouter A Duetz2 and Marco W Fraaije1*Abstract
Background: Baeyer-Villiger monooxygenases (BVMOs) represent a group of enzymes of considerable
biotechnological relevance as illustrated by their growing use as biocatalyst in a variety of synthetic applications.
However, due to their increased use the reproducible expression of BVMOs and other biotechnologically relevant
enzymes has become a pressing matter while knowledge about the factors governing their reproducible
expression is scattered.
Results: Here, we have used phenylacetone monooxygenase (PAMO) from Thermobifida fusca, a prototype Type I
BVMO, as a model enzyme to develop a stepwise strategy to optimize the biotransformation performance of
recombinant E. coli expressing PAMO in 96-well microtiter plates in a reproducible fashion. Using this system, the
best expression conditions of PAMO were investigated first, including different host strains, temperature as well
as time and induction period for PAMO expression. This optimized system was used next to improve
biotransformation conditions, the PAMO-catalyzed conversion of phenylacetone, by evaluating the best electron
donor, substrate concentration, and the temperature and length of biotransformation. Combining all optimized
parameters resulted in a more than four-fold enhancement of the biocatalytic performance and, importantly, this
was highly reproducible as indicated by the relative standard deviation of 1% for non-washed cells and 3% for
washed cells. Furthermore, the optimized procedure was successfully adapted for activity-based mutant screening.
Conclusions: Our optimized procedure, which provides a comprehensive overview of the key factors influencing
the reproducible expression and performance of a biocatalyst, is expected to form a rational basis for the
optimization of miniaturized biotransformations and for the design of novel activity-based screening procedures
suitable for BVMOs and other NAD(P)H-dependent enzymes as well.
Keywords: Baeyer-Villiger monoxygenase, Escherichia coli, Biocatalysis, Square deep-well microtiter plates, ScreeningBackground
Over the last decade, enzymes have attracted much at-
tention as they are efficient and extremely specific catalysts
in many synthetic chemical applications. Baeyer-Villiger-
monooxygenases (BVMOs) represent a notable example
of a group of enzymes that have emerged as powerful bio-
catalysts [1]. BVMOs incorporate one atom of molecular
oxygen into a carbon-carbon bond of an organic substrate
next to a carbonyl group while the other oxygen atom is* Correspondence: m.w.fraaije@rug.nl
1Laboratory of Biochemistry, Groningen Biomolecular Sciences and
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distribution, and reproduction in any mediumreduced to water. Most characterized BVMOs are NADPH-
dependent flavoproteins and belong to a sequence-related
family, called Type I BVMOs [2-4]. Phenylacetone
monooxygenase (PAMO) from Thermobifida fusca rep-
resents a prototype Type I BVMO, and its characterization
by us showed that it is a soluble, monomeric protein of
about 65 kDa and is well expressed in Escherichia coli
[5]. Substrate profiling revealed that it is mainly active
towards small aromatic ketones and sulfides [5-7]. How-
ever, PAMO is also able to convert larger substrates, al-
beit with a poor activity and selectivity [8]. In addition,
PAMO is remarkably thermostable and tolerant towards
organic solvents [5,9,10]. The determination of its atom-
ic structure showed that PAMO comprises two domains;tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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site sandwiched in between at the domain interface [11].
Moreover, a recent study, using complementary bio-
chemical and structural experiments, revealed that PAMO
and related enzymes function mainly as oxygen-activating
enzymes. These can react with any appropriate substrate
that is able to reach the catalytic center within the active
site [12]. The detailed structural and mechanistic under-
standing of PAMO as well as its remarkable stability
make this enzyme an attractive target for potential bio-
catalytic applications.
The reproducible expression of BVMOs and other bio-
technologically relevant enzymes has become a pressing
matter. Not only because of their growing use in a var-
iety applications, but also in the design of novel screen-
ing methods for directed-evolution experiments to identify
and isolate novel enzyme variants with the desired prop-
erties. Common strategies to optimize this typically rely
on small scale reactions, using either purified enzyme, or
whole cells expressing the enzyme of interest. Various
studies on cyclohexanone monooxygenase (CHMO), a
well-characterized BVMO from Acinetobacter sp., dem-
onstrate that whole cell biocatalytic systems are particu-
larly well-suited for this purpose. Different whole cell
biocatalytic systems, using Saccharomyces cerevisiae or
E. coli, have been employed successfully to investigate
and improve critical parameters for its expression as well
as conditions for CHMO-catalyzed biotransformations
[13-17]. Specifically, these systems were used either in
microscale or bench-scale reactions for substrate profiling,
analysis of substrate or product inhibition, comparison
of different expression hosts, assessment of biocatalyst
stability, analysis of oxygen supply, investigation of sub-
strate uptake, quantification of kinetic data, and the de-
tailed analysis of different microwell formats [15,17-24].
Combined, these studies emphasize the importance of a
robust host organism in combination with a powerful
expression system, and highlight the relevance of differ-
ent factors governing the expression of the target en-
zyme, such as expression temperature, time and period
of induction. Furthermore, they provide insight into con-
ditions that control the efficiency of biotransformation,
including the source of reducing power for in vivo co-
enzyme regeneration as well as substrate and product
inhibition.
Although valuable, the overall picture provided by
these studies is blurred because of the variety of host
organisms, different expression systems, various model
substrates and differing reaction conditions employed in
several studies for the same biocatalyst. To provide a
clear picture on this issue, we present in this study a ra-
tional and systematic approach to optimize the expres-
sion of a biocatalyst in a reproducible fashion. To this
end, we have used PAMO as a model BVMO andfollowed a stepwise strategy to improve the biotransfor-
mation performance of recombinant E. coli expressing
PAMO. Using a microscale approach, the best expres-
sion conditions for PAMO were investigated first, in-
cluding different host strains, temperature as well as
time and induction period for PAMO expression. Next,
this optimized system was used to improve conditions of
the biotransformation step, the PAMO-catalyzed conver-
sion of phenylacetone, by evaluating the best electron
donor, substrate concentration, and the temperature and
length of biotransformation. This resulted in an efficient
and highly reproducible PAMO whole cell biocatalyst
and, moreover, the optimized procedure was successfully
adapted for mutant screening. The strategy presented in
this study provides a valuable tool for the reproducible
optimization of bioconversions and in the design of
novel activity-based screening procedures suitable for




The optimization strategy presented in this study re-
volves around a recombinant E. coli strain expressing
PAMO because a whole cell biocatalyst is an excellent
system for this purpose as it is experimentally simple
and the use of whole cells instead of the purified enzyme
eliminates its costly isolation. To enable whole cell bio-
catalysis, we used an arabinose-inducible PAMO expres-
sion plasmid because the PBAD promoter allows a tightly
controlled and titratable overexpression unlike expres-
sion plasmids with a lac-type promotor [25].
Phenylacetone is the preferred substrate of PAMO and
is converted into benzyl acetate [5]. This substrate was
used as a model ketone throughout this study because
we previously established that it is readily taken up by
E. coli cells expressing PAMO and is converted into
benzyl acetate with high efficiency [26]. Moreover, the
formation of benzyl acetate by these cells can be quanti-
tatively assayed by gas chromatography [5,26,27]. This
procedure was, therefore, used to assess the effects of
the different optimization steps on the activity of the
PAMO whole cell biocatalyst. Furthermore, Stewart and
co-workers have shown that non-growing cells are able
to perform a CHMO-mediated model Beayer-Villiger
oxidation more efficiently than growing cells [21]. Ac-
cordingly, we used non-growing cells for the PAMO-
catalyzed biotransformation of phenylacetone.
In addition, all optimization steps were performed at a
microscale level by using 96 square deep-well microtiter
plates (96-sdMTPs) because this format is excellent for
evaluating different conditions in parallel as well as bac-
terial growth [28]. All conditions experimentally ad-
dressed were evaluated on the basis of the rate with
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ation and conditions yielding the best production were
included for the next step.
Best expression host, inducer concentration and
expression temperature
As a first step in our optimization strategy, we deter-
mined and improved critical factors that control the ex-
pression of PAMO. Out of these factors a powerful
expression host is of key importance for high-level over-
expression. E. coli is the most frequently used expression
host primarily because of capability to produce recom-
binant proteins in high yields. However, it has been
established that the production of the same target pro-
tein in various E. coli expression strains can differ dra-
matically [25,29]. Therefore, we established the best
PAMO expression host out of three standard E. coli ex-
pression strains (Top10, MC1061 and BL21(DE3). Fur-
thermore, the expression rate of the target protein is also
determined by the inducer concentration (L-arabinose)
and temperature [25,29], which were considered in our
initial analysis as well. To study these parameters, cells
of the aforementioned expression strains, harboring a
PAMO expression plasmid, were grown to saturation in
96-sdMTP at 25, 30 or 37°C in the presence of increas-
ing amounts of L-arabinose to induce PAMO expression.
For subsequent biotransformations, cells were centrifuged
and resuspended in assay mixture, containing 5 mM
phenylacetone, and samples were incubated for 3 hours
at 37°C. Following biotransformation, cells were re-
moved by centrifugation, the supernatant was extracted
with ethyl acetate and the amount of benzyl acetate was
analyzed by GC. As shown in Figure 1, no production of
benzyl acetate was detected when cells were grown in
the absence of arabinose, indicating that background ex-
pression of PAMO is virtually absent in all strains. Simi-
larly, no production of benzyl acetate was observed
under all experimental conditions with BL21(DE3) as an
expression host. In contrast, a significant formation of
benzyl acetate was observed with Top10 and MC1061
grown at 25°C or 30°C (Figure 1 A and B) in the pres-
ence of 0.002-0.2% L-arabinose. At a growth temper-
ature of 37°C, however, production of benzyl acetate was
only observed for Top10 induced for PAMO expression
with 0.02 or 0.2% L-arabinose (Figure 1 C).
To analyze the lack of product formation with BL21
(DE3) and the contrasting results obtained with Top10
and MC1061 when grown at 37°C, we investigated the
expression levels of PAMO in these strains. Therefore,
cells were grown to saturation in 96-sdMTP at 30°C or
37°C in the presence of 0.2% arabinose to induce PAMO
expression, a cell lysate of these cells was prepared and
analyzed by SDS-PAGE (Figure 1 D left panel). This
clearly showed that PAMO (indicated by an asterisk)was not expressed in BL21(DE3), thereby explaining the
absence of benzyl acetate after biotransformation. This
is probably caused by a poor induction of PAMO ex-
pression at 0.2% arabinose as BL21(DE3) is able to
metabolize arabinose, which, may, therefore, impair in-
duction of PAMO production. In contrast, PAMO was
nicely expressed in Top10 and MC1061 when grown at
both temperatures, which offered no explanation for the
striking difference in the production of benzyl acetate.
Although PAMO is expressed in MC1061 at 37°C, it is
conceivable that PAMO is produced in a non-active form
due to aggregation as insoluble inclusion bodies. Alter-
natively, the uptake of phenylacetone by MC1061 cells
may be impaired after growth at this temperature. To
distinguish between these two possibilities, the cell lyates
prepared from Top10 and MC1061 cells were subjected
to an ultracentrifugation step to obtain a soluble and in-
soluble fraction. SDS-PAGE analysis of these fractions
showed that PAMO (indicated by an asterisk) was al-
most exclusively present in the soluble fraction of Top10
and MC1061 grown at 30°C or 37°C (Figure 1 D right
panel). This, therefore, may suggest that benzyl acetate
was not produced during biotransformation due to an
impaired uptake of phenylacetone by MC1061 cells fol-
lowing growth at 37°C.
Based on these results, we decided to use Top10 as an
expression host for PAMO considering its overall robust
performance in combination with 0.2% L-arabinose and
30°C as standard conditions for expression in 96-sdMTP.Optimal induction time, induction period and effect of
external riboflavin addition
It has been established that there is a tight correlation
between the production of recombinant proteins by E.
coli and the time of induction e.g. the cellular growth
stage at which induction is initiated. For example, it
appears advantageous to induce the expression of the
target protein when cells have entered the log phase be-
cause at this stage cells are rapidly growing, which re-
quires a highly active translation machinery and this can
be exploited for the high-level production of recombi-
nant proteins [25,29]. However, several studies show that
the latter can also be obtained with late log or stationary
phase cells, displaying a (greatly) reduced growth rate
[30-32]. We, therefore, investigated the optimal induc-
tion time for PAMO expression. To this end, Top10 cells
harboring a PAMO expression plasmid were grown to
OD660 values of 0.4, 0.8 or 3.0, corresponding to mid log
phase, late log phase or stationary phase, respectively.
Aliquots of these cells were removed and induced for
PAMO expression with 0.2% L-arabinose at 30°C in
96-sdMTP for 3 hours. Following PAMO expression,
cells were harvested and used for the biotransformation
Figure 1 Top10 is the best expression host in combination with 0.2% L-arabinose and 30°C for the production of PAMO. The expression
of PAMO was investigated in the standard expression strains Top10, MC1061, and BL21(DE)3 transformed with an arabinose-inducible PAMO
expression plasmid. Cells were grown in the presence of increasing amounts of inducer (L-arabinose) in 96-sdMTP over night at 25°C (A),
30°C (B), or 37°C (C), respectively. The next day, cells were harvested and used for the bioconversion of phenylacetone in 96-sdMTP for 3 hours
at 37°C followed by the analysis of the benzyl acetate content. All experiments were performed in duplicate and the values obtained were
within 5% of each other. (D) PAMO expression in all tested strains. Cells were grown as described in the legend to Figure 1A at 30°C, or 37°C,
respectively. Subsequently, a cell lysate was prepared, which was further separated into a soluble (sol) and insoluble fraction (insol) for Top10 and
MC1061 by ultracentrifugation. Samples were analyzed by SDS-PAGE and Coomassie staining. The position of PAMO is indicated by an asterisk.
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acetate production revealed that late log and stationary
phase cells displayed a poor production of benzyl acetate
unlike mid log cells (Figure 2A). This is consistent with
the results from other studies, showing that the log
phase is the preferred time point to start the production
of recombinant proteins in E. coli [25,29].
Next, we studied the length of the induction period
because this is of significance with respect to high-level
overexpression of target proteins. To analyze the best in-
duction period for the expression of PAMO, Top10 cells
were grown to mid log phase and induced for PAMO
expression at 30°C in 96-sdMTP. Cells were collected,
starting 2 hours after induction, at 1 hour intervals and
used for the bioconversion of phenylacetone after which
the benzyl acetate content was analyzed (Figure 2B).
This showed that the production of benzyl actetate was
relatively constant up to 6 hours after induction. How-
ever, 4 hours of induction resulted in its best formation,
whereas benzyl acetate was no longer formed after
16 hours of induction probably due to a loss of PAMO
expression.
It has been reported that exogenously added riboflavin,
an FAD precursor which is taken up by E. coli unlike
FAD, improves the activity of different heterologously
expressed flavoproteins like pyridoxine 4-oxidase fromMicrobacterium luteolum [33]. Therefore, we studied
whether the performance of our PAMO whole cell bio-
catalyst could be improved by the addition of riboflavin
during the induction phase. As shown in Figure 2C, the
production of benzyl acetate was not significantly im-
proved by increasing amounts of riboflavin, suggesting
that sufficient FAD is available within E. coli cells to sus-
tain a proper PAMO expression.
Collectively, these data show that PAMO expression
should be initiated by addition of L-arabinose at mid log
phase for a period of 4 hours. Moreover, the addition of
riboflavin is not required to improve the activity of our
whole cell system.
Best biotransformation conditions
We next analyzed and improved basic conditions for the
biotransformation step, using our recombinant E. coli
strain in combination with the optimized expression
protocol from the previous stage. BVMOs are typically
NADPH-dependent and require an efficient system for
cofactor regeneration. To this end, several elegant solu-
tions have been presented that circumvent the addi-
tion of costly cofactors and work well for cell-free
systems and purified enzymes. These include a new gen-
eration of self-sufficient BVMO systems, comprising a
fusion between a thermostable variant of phosphite
Figure 2 The best activity of cells expressing PAMO is obtained with mid log cells, induced for PAMO expression for 4 hours and
without external addition of riboflavin. (A) Analysis of the best cellular growth stage for the induction of PAMO expression. Top10 cells were
grown to mid log, late log or stationary phase as described in the Methods section, harvested and grown in the presence of 0.2% L-arabinose in
96-sdMTP for 3 hours at 30°C. Following PAMO expression, cells were used for the bioconversion of phenylacetone in 96-sdMTP as described in
the legend to Figure 1. (B) Assessment of the best induction time for the production of PAMO. Top 10 cells were grown to mid log phase and
used for the production of PAMO in 96-sdMTP as described in the legend to Figure 2A. Starting 2 hours after induction, samples were removed
hourly and used for the bioconversion of phenylacetone in 96-sdMTP for 2 hours at 37°C followed by the analysis of the benzyl acetate content.
(C) Effect of external riboflavin addition. Mid log Top10 cells were induced for PAMO expression as described in the legend to Figure 2A in
the presence of the indicated amounts of riboflavin. Following PAMO expression, cells were used for the bioconversion of phenylacetone as
described in the legend to Figure 1 followed by the analysis of the benzyl acetate content. All experiments were performed in duplicate and the
values obtained were within 5% of each other.
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many BVMO-based whole cell systems rely on in vivo
coenzyme regeneration by the host, which can be im-
proved by coexpression of glucose-6-phosphate dehydro-
genase or external addition of carbohydrates [18-22,24].
We preferred to explore the latter approach as it is ex-
perimentally simpler than coexpression of glucose-6-
phosphate dehydrogenase or photochemical coenzyme
regeneration [36,37]. Therefore, we investigated the ef-
fect of different externally added carbohydrates (glucose,
glycerol and succinate) on the biocatalytic performance
of our PAMO whole cell system. These carbohydrates
were added during biotransformation, after which their
effect on the production of benzyl acetate was evaluated
(Figure 3A). This revealed that addition of glucose or
succinate hardly improved the biocatalytic performance
when compared to the negative control that did not
contain any externally added source of reducing power.
Remarkably, the addition of glycerol quadrupled the
production of benzyl acetate by our whole cell system
relative to the negative control, indicative of efficient
coenzyme regeneration upon addition of glycerol as shown
before [15,18,19]. Moreover, our data indicate thatglucose and succinate are not efficiently utilized by E.
coli for the regeneration of NADPH unlike glycerol. Pos-
sibly, these carbohydrates serve other metabolic pur-
poses in addition to biotransformation-related NADPH
regeneration. The latter is consistent with a recent study
involving a recombinant E. coli strain expressing the
Pseudomonas sp. styrene monooxygenase genes styAB
and glucose as a source of reducing power. These were
employed to show that biocatalysis-related NAD(P)H
consumption of this system was unexpected high, there-
by pointing towards other metabolic roles of glucose
during redox biocatalysis [38].
Furthermore, we investigated the effect of increasing
amounts of phenylacetone on the activity of our PAMO
whole cell system because it was recently shown that
high concentrations of relevant substrates were deleteri-
ous for the biocatalytic activity of other BVMO whole
cell systems [18,22,24]. To analyze this, cells expressing
PAMO were resuspended in an assay mix containing in-
creasing concentrations of phenylacetone and following
biotransformations, the benzyl acetate content of these
samples was assessed (Figure 3B). This showed that
15 mM of phenylacetone impairs the production of
Figure 3 The highest biocatalytic performance is achieved with glycerol as electron donor in combination with 5 mM phenylacetone
and 37°C for biotransformation. (A) Effect of externally added carbohydrates as source of reducing power. Phenylacetone was converted by
Top10 cells expressing PAMO in the presence of glucose, glycerol, or succinate after which the benzyl acetate content was analyzed. (B) Analysis
of the optimal substrate concentration. Top10 cells producing PAMO were used for the conversion of the indicated amounts of phenylacetone
followed by analysis of benzyl acetate production. (C) Influence of biotransformation temperature. Phenylacetone was converted by Top10 cells
expressing PAMO at 25°C, 30°C, or 37°C followed by analysis of the benzyl acetate content. (D) Assessment of best biotransformation period.
Top10 cells producing PAMO were used for the bioconversion of phenylacetone and the formation of benzyl acetate was analyzed at 1 hour
intervals. For all panels, cells were grown as described in the legend to Figure 2A, and biotransformations were performed as described in the
legend to Figure 1. All experiments were performed in duplicate and the values obtained were within 5% of each other.
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cell system increased substantially when 3 or 5 mM of
phenylacetone were used as evidenced by the higher
production of benzyl acetate under these conditions. In
addition, we also analyzed whether the production of
benzyl acetate could be improved by increasing the amount
of cells for biotransformation. This revealed that the best
formation of benzyl acetate was obtained with 0.1 mg
DCW and, moreover, its production was adversely af-
fected by increasing the amount of cells (data not shown).
It has been well established that the temperature is a
highly significant factor influencing the activity of en-
zymes and therefore also of whole cell biocatalytic sys-
tems [39]. Consequently, we investigated the effect of
the temperature on the biotransformation activity of
our whole cell system by performing the bioconversion
of phenylacetone at 25, 30, and 37°C. As shown in
Figure 3C, the production of benzyl acetate was relatively
moderate at 25 and 30°C. At 37°C, however, a three-fold
increase in the formation of benzyl acetate was obtained,
which is reflective of the optimal temperature of E. coli
and increased phenylacetone monooxygenase activity.
Finally, we sought to identify the best biotransform-
ation period in order to obtain the best production ofbenzyl acetate. For this purpose, we performed a time
course experiment in which the production of benzyl
acetate by our whole cell biocatalyst was analyzed at
1 hour intervals (Figure 3D). This revealed that the
amount of benzyl acetate increased almost linearly over
time for up to 4 hours, indicating that its formation rate
was remarkably constant during this period.
Combined, these data suggest that glycerol is the best
external source of reducing power for the regeneration
of NADPH during the PAMO-catalyzed biotransform-
ation of phenylacetone. Furthermore, the best biocataly-
tic performance was observed at 37°C in combination
with 5 mM of substrate. In contrast, the performance of
our PAMO whole cell biocatalyst was strongly affected
by decreasing the temperature, or increasing the sub-
strate concentration as well as the amount of cells for
biotransformation.
Efficiency of PAMO whole cell biocatalyst
After having established the best conditions for expres-
sion and biotransformation, we next wished to assess the
efficiency of our PAMO whole cell biocatalyst. To this
end, Top10 cells expressing PAMO were grown under
optimized conditions in 96- sdMTP and after 4 hours of
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ples were analyzed by SDS-PAGE and Coomassie stain-
ing after which the amount of PAMO was quantified by
gel band volume analysis. This revealed that 730 ng
(12 pmol) of PAMO was produced by 1 OD660 unit of
E. coli Top10 cells. Theoretically, 12 pmol PAMO is
able to produce 130 nmol of benzyl acetate per hour
given its kcat of 3 s
-1 for phenylacetone [27]. This theor-
etical production rate compares favorably with the ex-
perimentally determined formation rate of 117 nmol of
benzyl acetate per hour and shows that the biocatalytic
performance of our whole cell system is most likely not
impaired by oxygen transfer and substrate accessibility
as suggested for other whole-cell systems [23,40]. As noted
above, the biocatalytic performance was adversely af-
fected by increasing the amount of cells for biotrans-
formation which may point towards a limited oxygen
transfer under these conditions.
Analysis of reproducibility and use in activity-based
mutant screening
Reproducibility is an important requirement for an (in-
dustrial) biocatalytic process and in the design of novel
screening procedures for directed-evolution experiments.
We, therefore, studied first the reproducibility of the
biocatalytic performance of our whole cell system. To
this end, all optimized parameters for the expression as
well as biotransformation were combined and biotrans-
formations were performed in fourfold using either
washed E. coli cells expressing PAMO (Figure 4B) or
non-washed cells (Figure 4A). Subsequent analysis of the
benzyl acetate content revealed that the production of
this compound by cells that were washed with buffer
prior to biotransformation was slightly less when com-
pared to cells that did not receive this treatment as evi-
denced by a benzyl acetate productivity of 795 nmol/hr/
mg DCW for non-washed cells and 855 nmol/hr/mg
DCW for washed cells. Moreover, the results obtained
were highly reproducible as indicated by the relativeFigure 4 The biocatalytic performance of cells expressing PAMO is hi
biotransformation were combined and phenylacetone was converted by T
(A) prior to biotransformation. Cells were grown as described in the legend
the legend to Figure 1.standard deviation of 1% for non-washed cells and 3%
for washed cells.
Encouraged by these results, we wished to determine
next if our optimized protocol could be adapted success-
fully for screening purposes. Therefore, we investigated
whether E. coli cells expressing the previously described
PAMO mutant M446G [27] could be distinguished from
cells expressing the wild-type enzyme based on their ac-
tivity towards 1-indanone when all optimized conditions
for expression and biotransformation were combined com-
pared to the same set-up under non-optimized condi-
tions (e.g. stationary phase cells in combination with
0.02% L-arabinose and 37°C for protein expression in 96-
sdMTP). Of note, it has been established that 1-indanone
is not converted by wild-type PAMO unlike the M446G
variant, resulting in the unexpected lactone 1-isochromanone
[26,41]. Cells expressing the PAMO mutants P440L and
P440N were included as an additional control for spe-
cificity of the procedure because of their broadened
substrate scope and therefore potential activity with
1-indanone [42]. Following biotransformation, the
1-isochromanone content in all samples was analyzed by
GC, showing that 1-indanone was not converted by the
wild-type enzyme like the P440L and P440N variant
under all conditions tested. However, 1-isochromanone
was detected following bioconversion of 1-indanone by
cells expressing the M446G mutant as expected. In-
terestingly, a two-fold increase in the amount of 1-
isochromanone was obtained when cells producing the
M446G variant were subjected to the optimized protocol
relative to non-optimized conditions. Importantly, the
observed lack of 1-indanone conversion is not caused by
a poor expression because all PAMO variants were
equally well expressed under these experimental condi-
tions (data not shown), thereby pointing towards a low
reactivity of PAMO P440L and P440G with 1-indanone
like the wild-type enzyme and possibly a lowered uptake
of the substrate under non-optimized conditions. These
data, nevertheless, emphasize the potential of ourghly reproducible. All optimized parameters for expression and
op10 cells producing PAMO washed with buffer (B) or not washed
to Figure 2A, and biotransformations were performed as described in
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based screening procedures for BVMOs and other NAD
(P)H-dependent enzymes.
Conclusions
Driven by the growing demand for the reproducible ex-
pression of biocatalysts, we provide here a comprehensive
overview of key factors that control the reproducibility
and performance of a whole cell biocatalyst. Using re-
combinant E. coli producing PAMO, we have developed
a stepwise strategy to optimize the expression of PAMO
in a reproducible fashion. This system was first used to
explore the parameters that are of importance for
PAMO expression like: host strain, inducer concentra-
tion, temperature as well as time and length of induc-
tion. Furthermore, this whole cell system was used to
improve biotransformation conditions by evaluating the
best electron donor, substrate concentration, and the
temperature and length of biotransformation. Our re-
sults show that the type of expression host, cellular
growth stage at which induction is initiated and the
length of the induction period are amongst the most im-
portant factors that control the expression of PAMO. In
addition, we found that the type of carbohydrate used as
a source of reducing power (for regeneration of NAD(P)
H) during biotransformation and temperature are crucial
for a high biocatalytic performance. Specifically, a more
than four-fold enhancement of the biocatalytic perform-
ance was obtained when all optimized parameters were
combined, which was highly reproducible as indicated
by the relative standard deviation of 1% for non-washed
cells and 3% for washed cells. Of note, additional factors
known to influence the biocatalytic performance of a
whole cell system such as, for example, medium com-
position, coexpression of chaperones, oxygen transfer,
and substrate accessibility [23,40,43] were not consid-
ered in this study and therefore further improvement of
our whole cell system is conceivable. Moreover, we show
here that our optimized procedure can be adapted for
activity-based screening procedures for BVMOs.
In summary, the optimization strategy presented here
provides a clear picture on crucial factors controlling the
reproducible expression and performance of a whole cell
biocatalyst. Therefore, it is expected to form a rational
basis for the optimization of biotransformations and for
the design of novel activity-based screening procedures
suitable for BVMOs and probably other NAD(P)H-
dependent enzymes as well.
Methods
Enzymes, chemicals and media
Restriction enzymes were from Roche applied science
and New England Biolabs. Pfu Turbo DNA polymerase
was purchased from Stratagene. All chemicals wereobtained from ACROS organics, Jülich Fine Chemicals,
Roche Applied Sciences, and Sigma-Aldrich. Bacto tryp-
tone and yeast extract, which were used for the prepar-
ation of media, were purchased from Becton, Dickinson
& Company. All strains were routinely grown in Luria
Bertani medium (LB; per liter, 10 g tryptone, 5 g yeast
extract, 5 g NaCl) under aerobic conditions unless indi-
cated otherwise. Where appropriate, ampicillin (100 μg/ml)
was added to the culture medium.
Strains and plasmids
Strain TOP10 (Invitrogen) was used as a routine host
for all plasmid constructs. Strains Top10, MC1061 [44],
and BL21(DE3) [45] were used for whole cell biotrans-
formations in 96-sdMTP. The arabinose-inducible ex-
pression plasmid pPAMO [5] was used for the expression
of PAMO in all strains. The previously described PAMO
mutants M446G, P440N, and P440L were used for screen-
ing purposes [27,42]. All PAMO mutants were obtained
by site-directed mutagenesis, using the QuikChange kit
(Stratagene) and pPAMO as template. Nucleotide sequences
were verified by DNA sequencing (GATC, Konstanz).
Primer sequences are available upon request.
Biomass conversions
Biomass concentrations were analyzed spectrophotomet-
rically (Hitachi U-1100) at 660 nm and converted to dry
cell weight (DCW) using the equation 1 OD660 = 0.3 g
DCW/L [46,47].
Whole cell biotransformations in 96-sdMTP
For whole cell biotransformations, cells were typically
grown to saturation at 37°C and back-diluted 1:100 into
fresh LB containing appropriate antibiotics. These cul-
tures were grown to an OD660 value of 0.4 (correspond-
ing to mid log phase) at 17 °C overnight. The following
day, 1 OD660 unit of cells was harvested and resus-
pended in 800 μl of fresh LB, containing appropriate
antibiotics and 0.2% L-arabinose to induce the expres-
sion of PAMO. Cultures were grown for 4 hours in 96-
sdMTP (Waters, 2 ml square collection plate) at 30°C in
a Titramax 1000 shaker (Heidolph) at 1050 rpm, 1.5 mm
shaking diameter. Subsequently, cells were harvested
and resuspended in 500 μl phosphate-buffered saline,
containing 10 mM glycerol, 5 mM phenylacetone, or
5 mM 1-indanone for screening purposes. Bioconver-
sions were performed in 96-sdMTP (Waters, 2 ml
square collection plate) for 3 hours at 37°C with shaking
essentially as described [26]. Following bioconversions,
cells were removed by centrifugation and samples were
processed and analyzed by gas chromatography as
described [26,27]. Unless indicated otherwise, all experi-
ments were performed in duplicate and the values
obtained were within 5% of each other.
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Cells were grown to saturation at 37°C overnight and
the next day back-diluted 1:100 into fresh LB containing
appropriate antibiotics and 0.2% L-arabinose to induce
the expression of PAMO. Cultures were grown in 96-
sdMTP as described above and following the expression
of PAMO, cells were harvested and resuspended in 1 ml
of 50 mM Tris–HCl, pH= 7.5. This cell suspension was
subjected to two brief rounds of sonication, followed by
a clarifying spin to obtain a clarified cell lysate. This lys-
ate was further fractionated into a soluble and insoluble
fraction by ultracentrifugation (100,000 x g for 30 min at
4°C). Cellular fractions were normalized on the basis of
the OD660 and samples of these fractions, containing
equal OD660 units, were analyzed on standard 12% SDS-
PAGE gels followed by Coomassie blue staining to vi-
sualize protein bands.
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